European GMP approved Cephalosporine and Non-Cephalosporine facilities
	US-FDA soon.
	2006 sales of US$ 70 Million.
	86 registered brands with194 strengths.
	Broad portfolio of therapeutic categories.
	A number of European & USA registration dossiers/MA/ANDAs.
	8 in-licensed innovative products from Japanese , Korean and European partners.
	Market reach in 24 countries.
	More than 500 experienced and talented employees.